Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10335)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 2016; 22(1): 232-252 [PMID: 26755873 DOI: 10.3748/wjg.v22.i1.232] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/232.htm |
| Number | Citing Articles |
| 1 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
| 2 |
Ehab Mohammed. Improved liver function after high dose intravenous vitamin C and Helxior SC injections in a patient with hepatocellular carcinoma progressed after chemotherapy and radiation. Journal of Cancer Prevention & Current Research 2018; 9(4) doi: 10.15406/jcpcr.2018.09.00350
|
| 3 |
Onur Yaprak, Sencan Acar, Gokhan Ertugrul, Murat Dayangac. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World Journal of Gastrointestinal Oncology 2018; 10(10): 336-343 doi: 10.4251/wjgo.v10.i10.336
|
| 4 |
Aloysious D. Aravinthan, Silvio G. Bruni, Adam C. Doyle, Hla-Hla Thein, Nicolas Goldaracena, Assaf Issachar, Leslie B. Lilly, Nazia Selzner, Mamatha Bhat, Boraiah Sreeharsha, Markus Selzner, Anand Ghanekar, Mark S. Cattral, Ian D. McGilvray, Paul D. Greig, Eberhard L. Renner, David R. Grant, Gonzalo Sapisochin. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma. Annals of Surgical Oncology 2017; 24(7): 1843 doi: 10.1245/s10434-017-5789-3
|
| 5 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
|
| 6 |
Mamatha Bhat, Sergi Clotet-Freixas, Cristina Baciu, Elisa Pasini, Ahmed Hammad, Tommy Ivanics, Shelby Reid, Amirhossein Azhie, Marc Angeli, Anand Ghanekar, Sandra Fischer, Gonzalo Sapisochin, Ana Konvalinka. Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan. Clinical Proteomics 2021; 18(1) doi: 10.1186/s12014-021-09333-x
|
| 7 |
Julia Herreras, Tommaso Di Maira, Carmen Vinaixa, Fernando San Juan, Ángel Rubín, Marina Berenguer. Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation. Transplantation Direct 2019; 5(10): e487 doi: 10.1097/TXD.0000000000000934
|
| 8 |
Dong Ik Cha, Kyung Mi Jang, Seong Hyun Kim, Young Kon Kim, Honsoul Kim, Soo Hyun Ahn. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients. Korean Journal of Radiology 2020; 21(4): 402 doi: 10.3348/kjr.2019.0538
|
| 9 |
Alessandro Vitale, Federica Scolari, Alessandra Bertacco, Enrico Gringeri, Francesco D’Amico, Domenico Bassi, Francesco Enrico D’Amico, Paolo Angeli, Patrizia Burra, Quirino Lai, Umberto Cillo. Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?. Cancers 2021; 13(10): 2406 doi: 10.3390/cancers13102406
|
| 10 |
Roberto Santambrogio, Maurizio Vertemati, Matteo Barabino, Marco Antonio Zappa. Laparoscopic Microwave Ablation: Which Technologies Improve the Results. Cancers 2023; 15(6): 1814 doi: 10.3390/cancers15061814
|
| 11 |
Roberto Santambrogio, Matteo Barabino, Valentina D’Alessandro, Giulio Iacob, Enrico Opocher, Marco Gemma, Marco Antonio Zappa. Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?. Updates in Surgery 2021; 73(4): 1359 doi: 10.1007/s13304-021-01036-0
|
| 12 |
Kun Zhu, Lili Zhou, Manshu Zou, Shuangcheng Ning, Shulan Liu, Yilin Zhou, Ke Du, Xiaoqing Zhang, Xinhua Xia. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency. Journal of Pharmaceutical Sciences 2020; 109(6): 2038 doi: 10.1016/j.xphs.2020.03.001
|
| 13 |
Tommy Ivanics, Emmanuel Salinas-Miranda, Phillipe Abreu, Farzad Khalvati, Khashayar Namdar, Xin Dong, Dominik Deniffel, Andre Gorgen, Lauren Erdman, Kartik Jhaveri, Masoom Haider, Patrick Veit-Haibach, Gonzalo Sapisochin. A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker. Transplantation 2021; 105(11): 2435 doi: 10.1097/TP.0000000000003605
|
| 14 |
Jin Wang, Qungang Shan, Yong Liu, Hao Yang, Sichi Kuang, Bingjun He, Yao Zhang, Jingbiao Chen, Tianhui Zhang, Kevin J. Glaser, Cairong Zhu, Jun Chen, Meng Yin, Sudhakar K. Venkatesh, Richard L. Ehman. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. Journal of Magnetic Resonance Imaging 2019; 49(3): 719 doi: 10.1002/jmri.26250
|
| 15 |
Sunyoung Lee, Kyoung Won Kim, Woo Kyoung Jeong, Myeong-Jin Kim, Gi Hong Choi, Jin Sub Choi, Gi-Won Song, Sung-Gyu Lee. Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation. European Radiology 2020; 30(2): 987 doi: 10.1007/s00330-019-06424-0
|
| 16 |
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation. 2022; : 389 doi: 10.1007/978-3-030-82930-8_22
|
| 17 |
Yi-Hsuan Chuang, Hsin-You Ou, Chun-Yen Yu, Chao-Long Chen, Ching-Chun Weng, Leo Leung-Chit Tsang, Hsien-Wen Hsu, Wei-Xiong Lim, Tung-Liang Huang, Yu-Fan Cheng. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0264-y
|
| 18 |
Markus Bo Schoenberg, Hubertus Johann Wolfgang Anger, Julian Nikolaus Bucher, Gerald Denk, Enrico Narciso De Toni, Max Seidensticker, Joachim Andrassy, Martin Kurt Angele, Jens Werner, Markus Otto Guba. Liver Transplantation for Extended Criteria Hepatocellular Carcinoma Using Stable Response to Locoregional Therapy and Alpha-Fetoprotein as Selection Criteria. Visceral Medicine 2020; 36(6): 506 doi: 10.1159/000506752
|
| 19 |
Tyler A. Sandow, Stephen E. Arndt, Abeer A. Albar, Daniel A. DeVun, David S. Kirsch, Juan M. Gimenez, Humberto E. Bohorquez, Patrick J. Gilbert, Paul T. Thevenot, Kelley G. Nunez, Gretchen A. Galliano, Ari J. Cohen, Dennis Kay, Paul M. Gulotta. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. Radiology 2018; 286(3): 1072 doi: 10.1148/radiol.2017170731
|
| 20 |
Roberto Santambrogio, Claudia Cigala, Matteo Barabino, Marco Maggioni, Giovanna Scifo, Savino Bruno, Emanuela Bertolini, Enrico Opocher, Gaetano Bulfamante. Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathology. Liver International 2018; 38(2): 312 doi: 10.1111/liv.13524
|
| 21 |
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
|
| 22 |
Nourhan Badwei. Molecular Clues for Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Journal of Clinical and Experimental Hepatology 2023; 13(5): 804 doi: 10.1016/j.jceh.2023.02.006
|
| 23 |
Tommaso Giuliani, Eva Montalvá, Javier Maupoey, Andrea Boscá, Ana Hernando, David Calatayud, Vicente Navarro, Angel Rubín, Carmen Vinaixa, Rafael López-Andújar. Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments. Digestive Surgery 2024; 41(4): 181 doi: 10.1159/000539460
|
| 24 |
Hae Won Lee, Kyung-Suk Suh. Liver transplantation for advanced hepatocellular carcinoma. Clinical and Molecular Hepatology 2016; 22(3): 309 doi: 10.3350/cmh.2016.0042
|
| 25 |
Joseph DiNorcia, Sander S. Florman, Brandy Haydel, Parissa Tabrizian, Richard M. Ruiz, Goran B. Klintmalm, Srinath Senguttuvan, David D. Lee, C. Burcin Taner, Elizabeth C. Verna, Karim J. Halazun, Maarouf Hoteit, Matthew H. Levine, William C. Chapman, Neeta Vachharajani, Federico Aucejo, Mindie H. Nguyen, Marc L. Melcher, Amit D. Tevar, Abhinav Humar, Constance Mobley, Mark Ghobrial, Trevor L. Nydam, Beth Amundsen, James F. Markmann, Jennifer Berumen, Alan W. Hemming, Alan N. Langnas, Carol A. Carney, Debra L. Sudan, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Abbas Rana, Michael L. Kueht, Christopher M. Jones, Thomas M. Fishbein, Daniela Markovic, Ronald W. Busuttil, Vatche G. Agopian. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 2020; 271(4): 616 doi: 10.1097/SLA.0000000000003253
|
| 26 |
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
|
| 27 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. Journal of Surgical Oncology 2019; 120(7): 1126 doi: 10.1002/jso.25721
|
| 28 |
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
|
| 29 |
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
|
| 30 |
Louis Leong-Liung Ling, Chien-Chin Hsu, Chee-Chien Yong, Ahmed M. Elsarawy, Yi-Chia Chan, Chih-Chi Wang, Wei-Feng Li, Ting-Lung Lin, Fang-Ying Kuo, Yu-Fan Cheng, Li-Man Lin, Chao-Long Chen, Chih-Che Lin. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study. International Journal of Surgery 2019; 69: 124 doi: 10.1016/j.ijsu.2019.07.035
|
| 31 |
Jiong‐Ze Fang, Li Xiang, Yang‐Ke Hu, Yong Yang, Hong‐Da Zhu, Cai‐De Lu. Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?. Clinical Transplantation 2020; 34(5) doi: 10.1111/ctr.13831
|
| 32 |
Mohamed Elgazzar, Tary Salman, Eman Abdelsameea, Mohamed Akl, Nabil Omar, Mohamed Abdel-Samiee, Shrif Abas, Mohmoud Elsakhawy, Ahmed Elsherif, Ibrahim Abdelkader, Dina Elazab, Nermine Ehsan, Mohamed Mohamady, Mohamed El-Kassas, Hazem Metwaly Omar. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01249-4
|